We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:
BrightSpring Health Services, Inc. (BTSG - Free Report) : This parent company of healthcare service lines which, provide complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
BrightSpring Health Services, Inc. Price and Consensus
BrightSpring Health Services' shares gained 15.7% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.
XP (XP - Free Report) : This technology-driven financial services platform which offers financial products and services primarily in Brazil, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
Catalyst Pharmaceuticals (CPRX - Free Report) : This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals shares gained 3.6% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.
View the Zacks #1 Rank List
Image: Bigstock
Best Momentum Stock to Buy for March 4th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:
BrightSpring Health Services, Inc. (BTSG - Free Report) : This parent company of healthcare service lines which, provide complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
BrightSpring Health Services, Inc. Price and Consensus
BrightSpring Health Services, Inc. price-consensus-chart | BrightSpring Health Services, Inc. Quote
BrightSpring Health Services' shares gained 15.7% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.
BrightSpring Health Services, Inc. Price
BrightSpring Health Services, Inc. price | BrightSpring Health Services, Inc. Quote
XP (XP - Free Report) : This technology-driven financial services platform which offers financial products and services primarily in Brazil, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
XP Inc. Price and Consensus
XP Inc. price-consensus-chart | XP Inc. Quote
XP’s shares gained 3.2% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.
XP Inc. Price
XP Inc. price | XP Inc. Quote
Catalyst Pharmaceuticals (CPRX - Free Report) : This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote
Catalyst Pharmaceuticals shares gained 3.6% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.
Catalyst Pharmaceuticals, Inc. Price
Catalyst Pharmaceuticals, Inc. price | Catalyst Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here